Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-21

Clinical Trial Update: Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia. [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ziprasidone to olanzapine in schizophrenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)
  • olanzapine (olanzapine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED